Variants in <i>ATP6V0C</i> are associated with Dravet‐like developmental and epileptic encephalopathy

Here we describe two adult patients with Dravet-like syndrome and pathogenic/likely pathogenic variants in ATP6V0C. We propose that abnormal ATP6V0C function can, at the severe end of the clinical spectrum, be associated with Dravet-like phenotype. This is relevant, as these patients would not qualify for disease-modifying antisense nucleotide or gene therapies targeting SCN1A.

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2025-03-14
DOI
https://doi.org/10.1111/epi.18346
Citations
3
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
4.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Variants in ATP6V0C are associated with Dravet‐like developmental and epileptic encephalopathy

Kette D. R. Valente, Rima Nabbout, Paula Marques, Miriam S. Reuter et al.
3 citations
Epilepsia
Epilepsy research and treatment
4.41
article

Variants in ATP6V0C are associated with Dravet‐like developmental and epileptic encephalopathy

Kette D. R. Valente, Rima Nabbout, Paula Marques, Miriam S. Reuter, Guido Rubboli, Annapurna Poduri, Elena Gardella, Andreas Brunklaus, Kelly G. Knupp, Ángel Aledo‐Serrano, Tristan T. Sands, Danielle Molinari Andrade, Ingrid Eileen Scheffer, Amy Schneider, Ricardo Morcos, Marlene Rong, Allan Bayat, Quratulain Zulfiqar Ali, Elaine C. Wirrell, Stéphane Auvin, Rikke S. Møller, Farah Qaiser, Joseph Sullivan, Ilakkiah Chandran
article en
3 citations

Abstract

Here we describe two adult patients with Dravet-like syndrome and pathogenic/likely pathogenic variants in ATP6V0C. We propose that abnormal ATP6V0C function can, at the severe end of the clinical spectrum, be associated with Dravet-like phenotype. This is relevant, as these patients would not qualify for disease-modifying antisense nucleotide or gene therapies targeting SCN1A.

EpilepsiaVol. 66(6)
University of Copenhagen (DK), Boston Children's Hospital (US), Mayo Clinic (US), Harvard University (US), Inserm (FR), The University of Melbourne (AU), Délégation Paris 7 (FR), University of Southern Denmark (DK), University of California, San Francisco (US), University of Toronto (CA), Institut Universitaire de France (FR), Université Paris Cité (FR), Toronto Western Hospital (CA), Royal Hospital for Children (GB), Hospital for Sick Children (CA), WinnMed (US), Sorbonne Paris Cité (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Robert-Debré (FR), Danish Gas Technology Centre (Denmark) (DK), SickKids Foundation (CA), Hospital Universitário da Universidade de São Paulo (BR), Epilepsy Action (GB), Epilepsy Foundation (AU), Ontario Brain Institute (CA), Austin Health (AU), NeuroDiderot (FR), University of Colorado Anschutz Medical Campus (US), Columbia University (US), University of Glasgow (GB), European Environment Agency (DK), Universidad Europea de Madrid (ES), University of Colorado Denver (US)
Good health and well-being
Openalex Percentile: Top 7%
Epilepsy research and treatment
4.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.